You just read:

Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Rheumatoid Arthritis

News provided by

Coherus Biosciences, Inc.

23 Jun, 2014, 18:31 BST